Department of Cardiovascular Medicine Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
J Cardiovasc Electrophysiol. 2020 May;31(5):1182-1186. doi: 10.1111/jce.14425. Epub 2020 Mar 15.
Cardiac resynchronization therapy (CRT) is indicated in patients with medically refractory heart failure and wide QRS duration. While much is known about predictors of left ventricular (LV) remodeling after CRT implantation and short-term mortality, limited data exist on long-term outcomes after CRT placement.
We retrospectively reviewed all patients undergoing CRT implantation at our center between 2003 and 2008 and examined mortality using institutional electronic records, social security death index, and online obituary search. We included only patients with preimplant echoes with LV ejection fraction (LVEF) 35% or below. Variable selection was performed using stepwise regression and models were compared using goodness-of-fit criteria. A final model was validated with the bootstrap regression method.
Out of the 877 CRT patients undergoing implantation during this time, 287 (32.7%) survived longer than 10 years. Significant (P < .05) predictors of survival in our multivariate model were age, left ventricular diastolic diameter, sex, presence of nonischemic vs ischemic cardiomyopathy, QRS duration, atrial fibrillation, BNP levels, and creatinine levels at the time of CRT implantation. A model using the odds ratios from these variables had a receiver operating curve with an area under the curve score of 0.816 (standard error, 0.019) at predicting survival or freedom from LVAD or heart transplant for longer than 10 years after CRT implantation. The specificity for factors 3 or above and 5 or above was 68% and 77%, respectively.
A large proportion of patients are still alive 10 years after CRT implantation. Variables at the time of CRT implant can help provide prognostic information to patients and electrophysiologists to determine the long-term benefit and survival of patients after CRT implantation.
心脏再同步治疗(CRT)适用于药物难治性心力衰竭和宽 QRS 持续时间的患者。虽然人们对 CRT 植入后左心室(LV)重构和短期死亡率的预测因素了解很多,但关于 CRT 放置后的长期结果的数据有限。
我们回顾性地审查了 2003 年至 2008 年期间在我们中心接受 CRT 植入的所有患者,并使用机构电子记录、社会保障死亡指数和在线讣告搜索来检查死亡率。我们仅包括植入前 LV 射血分数(LVEF)为 35%或以下的患者进行 echocardiography。使用逐步回归进行变量选择,并使用拟合优度标准比较模型。使用自举回归方法验证最终模型。
在此期间,在 877 例接受 CRT 植入的患者中,有 287 例(32.7%)存活时间超过 10 年。我们多变量模型中存活的显著(P < .05)预测因素包括年龄、LV 舒张直径、性别、非缺血性与缺血性心肌病的存在、QRS 持续时间、心房颤动、BNP 水平和 CRT 植入时的肌酐水平。使用这些变量的比值比的模型在预测 CRT 植入后 10 年以上的生存或免于 LVAD 或心脏移植方面具有 0.816(标准误差,0.019)的曲线下面积评分的接收者操作曲线。对于因素 3 或更高和 5 或更高的特异性分别为 68%和 77%。
在 CRT 植入后 10 年,仍有很大比例的患者存活。CRT 植入时的变量可以帮助为患者和电生理学家提供预后信息,以确定 CRT 植入后患者的长期获益和生存率。